| Año publicación | Título | Código | Acrónimo | Tipo | Área | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial. | 24.001 | PREVESTATGx | RESULTADOS | Medicina de Familia |